Influence of Pretransplant Panel-Reactive Antibody on Outcomes in 8,160 Heart Transplant Recipients in Recent Era
Lois U. Nwakanma(Johns Hopkins University), John V. Conte(Commonwealth Medical College), Eric S. Weiss(University of Pittsburgh), Jason A. Williams(Johns Hopkins University), Stuart D. Russell(Duke Medical Center), William A. Baumgartner(New York University)
Cited by 215
Related Papers
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients
|Journal of the American College of Cardiology|2010|583
Reduced Kidney Function as a Risk Factor for Incident Heart Failure
|Journal of the American Society of Nephrology|2007|449
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
|Blood|2018|402
Low Thromboembolism and Pump Thrombosis With the HeartMate II Left Ventricular Assist Device: Analysis of Outpatient Anti-coagulation
|The Journal of Heart and Lung Transplantation|2009|303